Aeterna Zentaris (NASDAQ:AEZS) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright decreased their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating […]